Yashoda Hospitals conducts First International Conference & Live Workshop on ‘EBUS & Advanced Lung Cancer Treatments’

More than 200 leading pulmonologists from India and all over the world attended the conference. The programme had eminent pulmonologists of international repute including Dr. Lorenzo Corbetta from Italy, Dr. Melvin Tay from Singapore, Dr. Angela Takano from Singapore, and Dr. Aji Kavidasan from London, UK.

Participants have gained exposure to a real-time EBUS & Advanced Lung Cancer Treatment procedures, patient selection, indications, procedure performance & complications overview. The programme included guest lectures, panel discussions, workshop demo & live demonstrations well organized by Yashoda Hospitals led by senior interventional pulmonologists Dr. Hari Kishan Gonuguntla along with Dr. M. Gangadhar Reddy and Dr. Y. Gopi Krishna.

India’s first ever International Interventional Pulmonology Conference & Live Workshop by Yashoda Hospitals on EBUS, the ultra-advanced diagnostic procedure in staging & treating lung cancer effectively was very successful. This world-class conference with the live workshop was organized by the Department of Interventional Pulmonology of Yashoda Hospitals, Hyderabad. The programme was inaugurated by Dr. Pavan Gorukanti, Director – Yashoda Hospitals Group. This innovative & state of the art technology is gaining rapid acceptance in diagnosis, staging and treatment of lung cancers, TB & other acute lung diseases effectively.

Yashoda Hospitals is pioneering in ‘Interventional Pulmonology’ and is one among select few centers in the world offering all the latest advances such as EBUS, Radial EBUS, navigational bronchoscopy, bronchial thermoplasty, cyrobiopsy, robotic VATS, lung transplant and more under one roof.

“Lung cancer is one of the commonest cancers and cause of cancer-related deaths all over the world. It accounts for 14.5% of all new cancer cases & 20% of cancer-related deaths worldwide. There were over 2 million new lung cancer cases estimated every year In India, lung cancer constitutes 7.5% of all new cancer cases & 10% of all cancer-related deaths in India. But with early detection and advances in treatment including targeted therapy, and immunotherapy, the clinical outcomes have improved. EBUS is a revolutionary, precision technology for the early diagnosis of Lung Cancers.” said Dr. Pavan Gorukanti, Director of Yashoda Hospitals.